Smith J, Arunachalam P, Legere T, Cavacini L, Hunter E, Pulendran B
Vaccines (Basel). 2025; 12(12.
PMID: 39772048
PMC: 11680376.
DOI: 10.3390/vaccines12121386.
Ocon B, Xiang M, Bi Y, Tan S, Brulois K, Ayesha A
Nature. 2024; 635(8039):736-745.
PMID: 39293486
PMC: 11887596.
DOI: 10.1038/s41586-024-08043-2.
Xu Y, Jiang X, Zhou Z, Ferguson T, Obliosca J, Luo C
Part Part Syst Charact. 2022; 39(5).
PMID: 36186663
PMC: 9523582.
DOI: 10.1002/ppsc.202200011.
Hartwell B, Melo M, Xiao P, Lemnios A, Li N, Chang J
Sci Transl Med. 2022; 14(654):eabn1413.
PMID: 35857825
PMC: 9835395.
DOI: 10.1126/scitranslmed.abn1413.
Kiyono H, Yuki Y, Nakahashi-Ouchida R, Fujihashi K
Int Immunol. 2021; 33(12):767-774.
PMID: 34436595
PMC: 8633596.
DOI: 10.1093/intimm/dxab056.
Activation of Conjunctiva-Associated Lymphoid Tissue in Patients With Infectious Keratitis Using In Vivo Confocal Microscopy.
Liu Y, Zhu R, Jin X, Wang Y, Shi Y, Zhang N
Invest Ophthalmol Vis Sci. 2021; 62(10):27.
PMID: 34427624
PMC: 8399476.
DOI: 10.1167/iovs.62.10.27.
A Zigzag but Upward Way to Develop an HIV-1 Vaccine.
Wen Z, Sun C
Vaccines (Basel). 2020; 8(3).
PMID: 32911701
PMC: 7564621.
DOI: 10.3390/vaccines8030511.
The Age of Cyclic Dinucleotide Vaccine Adjuvants.
Gogoi H, Mansouri S, Jin L
Vaccines (Basel). 2020; 8(3).
PMID: 32823563
PMC: 7563944.
DOI: 10.3390/vaccines8030453.
Chemically Synthesized Lipid A Shows a Potent and Safe Nasal Vaccine Adjuvant Activity for the Induction of -Specific IgA and Th17 Mediated Protective Immunity.
Yoshii K, Hosomi K, Shimoyama A, Wang Y, Yamaura H, Nagatake T
Microorganisms. 2020; 8(8).
PMID: 32718009
PMC: 7464877.
DOI: 10.3390/microorganisms8081102.
Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection.
Forsyth V, Himpsl S, Smith S, Sarkissian C, Mike L, Stocki J
mBio. 2020; 11(2).
PMID: 32345645
PMC: 7188996.
DOI: 10.1128/mBio.00555-20.
Nasal double DNA adjuvant induces salivary FimA-specific secretory IgA antibodies in young and aging mice and blocks Porphyromonas gingivalis binding to a salivary protein.
Kobuchi K, Kataoka K, Taguchi Y, Miyake T, Umeda M
BMC Oral Health. 2019; 19(1):188.
PMID: 31426773
PMC: 6700810.
DOI: 10.1186/s12903-019-0886-2.
Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain.
Shim B, Cheon I, Lee E, Park S, Choi Y, Jung D
J Immunol Res. 2018; 2018:9830701.
PMID: 29707588
PMC: 5863330.
DOI: 10.1155/2018/9830701.
Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates.
Bekri S, Bourdely P, Luci C, Dereuddre-Bosquet N, Su B, Martinon F
Front Immunol. 2017; 8:63.
PMID: 28203239
PMC: 5285372.
DOI: 10.3389/fimmu.2017.00063.
Phenotype and function of nasal dendritic cells.
Lee H, Ruane D, Law K, Ho Y, Garg A, Rahman A
Mucosal Immunol. 2015; 8(5):1083-98.
PMID: 25669151
PMC: 4532662.
DOI: 10.1038/mi.2014.135.
How can we design better vaccines to prevent HIV infection in women?.
Rafferty H, Sibeko S, Rowland-Jones S
Front Microbiol. 2014; 5:572.
PMID: 25408686
PMC: 4219488.
DOI: 10.3389/fmicb.2014.00572.
Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection.
Olivera N, Castuma C, Hozbor D, Gaillard M, Rumbo M, Gomez R
Biomed Res Int. 2014; 2014:421486.
PMID: 24982881
PMC: 4052895.
DOI: 10.1155/2014/421486.
An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination.
Binjawadagi B, Dwivedi V, Manickam C, Ouyang K, Torrelles J, Renukaradhya G
Int J Nanomedicine. 2014; 9:1519-35.
PMID: 24711701
PMC: 3969340.
DOI: 10.2147/IJN.S59924.
Neonatal immunization with respiratory syncytial virus glycoprotein fragment induces protective immunity in the presence of maternal antibodies in mice.
Noh Y, Shim B, Cheon I, Rho S, Kim H, Choi Y
Viral Immunol. 2013; 26(4):268-76.
PMID: 23869549
PMC: 3739953.
DOI: 10.1089/vim.2012.0087.
Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1.
Mohan T, Mitra D, Rao D
Immunol Res. 2013; 58(1):139-53.
PMID: 23666811
DOI: 10.1007/s12026-013-8428-5.
New age adjuvants and delivery systems for subunit vaccines.
Kurella S, Manocha M, Sabhnani L, Thomas B, Rao D
Indian J Clin Biochem. 2012; 15(Suppl 1):83-100.
PMID: 23105272
PMC: 3454077.
DOI: 10.1007/BF02867548.